Edwards Lifesciences Corp
- Stock
- Ticker EW
- ISIN US28176E1082
- NYSE
Performance, volatility and drawdowns of Edwards Lifesciences Corp since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $34,254. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −54.3% in 07/2024, measured from the peak in 12/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 1,386 | 1,413 | 1,532 | 1,553 | 1,570 | 1,649 | 1,741 | 1,716 |
| Gross profit | 1,094 | 1,111 | 1,188 | 1,208 | 1,227 | 1,286 | 1,349 | 1,346 |
| Operating income | 313 | 395 | 411 | 307 | 151 | 478 | 513 | 299 |
| EBITDA | 355 | 431 | 449 | 346 | 194 | 519 | 556 | 344 |
| Net income | 386 | 358 | 333 | 291 | 91 | 381 | 242 | 308 |
| Earnings per share | 0.65 | 0.61 | 0.56 | 0.50 | 0.16 | 0.66 | 0.42 | 0.53 |
| Balance sheet | ||||||||
| Total assets | 13,055 | 13,022 | 13,489 | 13,272 | 13,697 | 13,321 | 13,867 | 14,144 |
| Liabilities | 2,992 | 2,831 | 2,882 | 3,067 | 3,360 | 2,994 | 3,142 | 3,183 |
| Equity | 9,998 | 10,129 | 10,545 | 10,205 | 10,338 | 10,328 | 10,618 | 10,861 |
| Cash | 3,045 | 3,141 | 3,273 | 2,686 | 2,938 | 2,446 | 2,907 | 3,111 |
| Long-term debt | 598 | 598 | 598 | 598 | 598 | 599 | 599 | 599 |
| Cash flow | ||||||||
| Operating cash flow | -128 | 280 | 290 | 574 | 451 | 44 | 652 | 570 |
| Capital expenditure | -50 | -56 | -49 | -58 | -97 | -65 | -67 | -64 |
| Free cash flow | -177 | 224 | 241 | 516 | 354 | -21 | 585 | 507 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2019 at +52.3%, weakest 2022 at −42.4%. 7 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 4 Nov 2026 | $0.53 |
| 4 Aug 2026 | $0.42 |
| 6 May 2026 | $0.66 |
| 25 Feb 2026 | $0.16 |
| 5 Nov 2025 | $0.50 |
| 6 Aug 2025 | $0.56 |
| 6 May 2025 | $0.61 |
| 28 Feb 2025 | $0.65 |
| 6 Nov 2024 | $5.13 |
| 31 Jul 2024 | $0.61 |
| 29 Apr 2024 | $0.58 |
| 12 Feb 2024 | $0.61 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €53bn
- Market cap in trading currency
- $58.6bn
- Enterprise value
- $54.5bn
- P/E
- 57.5
- P/S
- 8.77
- P/B
- 5.39
- EV/Sales
- 8.17
- EV/EBITDA
- 33.8
- Earnings yield
- 1.7%
- FCF yield
- 2.4%
Results (last four quarters)
- Revenue
- $6.67bn
- Gross profit
- $5.21bn
- EBITDA
- $1.61bn
- Net income
- $1.02bn
- Earnings per share
- $1.77
- Revenue per share
- $11.61
- Revenue growth
- +10.5%
- Earnings growth
- +5.6%
Profitability
- Gross margin
- 78.0%
- Operating margin
- 21.6%
- Net margin
- 15.3%
- Return on equity
- 9.7%
- Return on assets
- 7.2%
Balance sheet and cash flow
- Cash
- $4.64bn
- Cash per share
- $8.08
- Financial debt
- $599m
- Debt/equity %
- 6
- Current ratio
- 4.60
- Book value per share
- $18.89
- Operating cash flow
- $1.72bn
- Free cash flow
- $1.42bn
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 575m
- Volume
- 3.51m
- Avg. volume 3 months
- 3.85m
- Relative volume
- 0.9
Price and technicals
- Price
- $101.85
- 1 day
- −2.0%
- 52-week high
- $107.15
- 52-week low
- $75.87
- Distance to 52-week high
- −4.9%
- Distance to 52-week low
- +34.2%
- Distance to 50-day line
- +10.4%
- Distance to 200-day line
- +17.2%
- RSI (14)
- 59
- Volatility 1M
- 27.6%
Performance
- 1 week
- −4.9%
- 1 month
- +13.1%
- 3 months
- +12.5%
- 6 months
- +18.7%
- YTD
- +19.5%
- 1 year
- +18.4%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has EW performed since 11/2016?
$10,000 grew to $34,254 by 20 Nov 2026, which is +13.1% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is EW?
Volatility was 29.4% per year, measured on monthly returns. The largest decline from a peak was −54.3%, with the low in 07/2024.
How does EW compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, EW returned +13.1% at 29.4%. The correlation of monthly returns was 0.45; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.